Results 191 to 200 of about 76,164 (271)

A Natural Resource‐Based View of Circular Economy Practices in the Pharmaceutical Industry

Business Strategy and the Environment, Volume 35, Issue 3, Page 4587-4605, March 2026.
ABSTRACT Pharmaceutical industry is facing escalating environmental sustainability issues including gaseous emissions, waste generation, and excessive consumption of energy and non‐renewable materials. Nevertheless, the adoption of sustainable business models such as the circular economy (CE) is still in its infancy in this sector due to complex ...
Amna Farrukh, Muhammad Sohaib Sajjad
wiley   +1 more source

Serum Sickness After Cosmetic Botulinum Toxin Type A Injections. [PDF]

Aesthet Surg J Open Forum
DeLuca-Pytell D, Dass K, Audia G, Busuito E.   +3 more
europepmc   +1 more source

Modalities of Vitamin D Administration to Preterm Infants: Impact on 25 OH Vitamin D Levels

Acta Paediatrica, Volume 115, Issue 4, Page 985-987, April 2026.
Sophie Laborie, Manon Breniaux, Justine Bacchetta, Marine Butin   +3 more
wiley   +1 more source

Demystifying Piecewise and Localized Scatter Correction Methods

Journal of Chemometrics, Volume 40, Issue 3, March 2026.
ABSTRACT Multiplicative scatter is a common source of noise in near‐infrared spectroscopy and other related instrumental techniques. A wide variety of methods are commonly used for the correction of multiplicative scatter. However, the majority of such methods assume that the parameters that describe the scatter are constant throughout the measured ...
Cannon Giglio, Jean‐Michel Roger, Erik Andries   +2 more
wiley   +1 more source

Nucleic Acid Nanoparticles Redefine Traditional Regulatory Terminology: The Blurred Line between Active Pharmaceutical Ingredients and Excipients. [PDF]

ACS Nano Med
Kozlov S, Panigaj M, Rebolledo L, Bhaskaran H, Afonin KA.   +4 more
europepmc   +1 more source

Synthesis and Characterization of Metal‐doped Chitosan‐Hydroxyapatite Composites for the Tuning of Properties: Evaluating Antibacterial Activity and Drug Release

International Journal of Ceramic Engineering &Science, Volume 8, Issue 2, March 2026.
ABSTRACT The search for versatile, sustainable composites with enhanced antibacterial properties has been driven by the rising threat of antibiotic‐resistant diseases and the need for advanced biomaterials for medication delivery. This work involves the synthesis and thorough characterization of chitosan‐hydroxyapatite (CS‐HAp) composites derived from ...
Bipul Mondal Sagar, Kazi Imtiaz Ahmed Nakib, Sanjida Khan, Subarna Sandhani Dey, Md. Lawshan Habib, Samina Ahmed, Md. Sahadat Hossain   +6 more
wiley   +1 more source

UPLC-QDA combined with pharmacology and chemometrics to analyze the correlation between the processing technology and color of Siegesbeckiae herba. [PDF]

RSC Adv
Hou A, Yu C, Li J, Yang L, Kuang H, Zhou Y, Jiang H.   +6 more
europepmc   +1 more source

Comparative Bioequivalence and Safety Evaluation of Ibuprofen/Phenylephrine Hydrochloride Fixed‐Dose Combination Tablets in Healthy Chinese Volunteers

Clinical Pharmacology in Drug Development, Volume 15, Issue 3, March 2026.
Abstract This single‐center, randomized, open‐label bioequivalence program compared two fixed‐dose combination (FDC) tablets containing ibuprofen (200 mg) and phenylephrine hydrochloride (10 mg) from different manufacturers in healthy Chinese adults under fasting and fed conditions. A three‐period, partially replicated crossover design was used for the
Menghan Ye, Rui Zhang, Jing Wan, Jinping Zhou, Pengpeng Guo, Dianwen Yu, Peixia Li, Yani Liu, Shaojun Shi   +8 more
wiley   +1 more source

A survey of regulatory recommendations for waivers of <i>in vivo</i> bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2. [PDF]

J Pharm Pharm Sci
García-Arieta A, Tam A, Tiseyra F, Fernandes EAF, Soares KCC, Pereira RS, Potthast H, Mettke K, Chang YW, Hsu LF, Su YL, Martínez ZR, Divinsky M, Blake K, Braddy AC, Rodrigues C, Toh T, Aurela EG, González LCA, Jones B, Kim SH, Ahn C, Yun E, Kuribayashi R, Shimojo K, Kasuga M, Makino J, Raffel J, van Oudtshoorn J, Tabane P, Alzenaidy B, AlHarbi M, Alharf A, BinAjlan A, Walther C, Roost MS, Crane C, Lee K.   +37 more
europepmc   +1 more source

Effects of High‐ and Low‐Fat Meals on the Bioavailability and Pharmacokinetics of Votoplam, a HTT Gene Splicing Modifier

Clinical Pharmacology in Drug Development, Volume 15, Issue 3, March 2026.
Abstract Votoplam is a novel, orally bioavailable, small molecule HTT gene splicing modifier that is being developed for the treatment of Huntington's disease. This was a single dose, open‐label, two‐period, crossover food effect study that evaluated the effect of high‐ and low‐fat meals on 20 mg votoplam in healthy participants. There was a washout of
Lucy Lee, Amy‐Lee Richards, Nageswara Reddy, Brian Beers, Lee Golden, Ronald Kong   +5 more
wiley   +1 more source